SANA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 31.10%

Insider Buying (Last 12 Months): $9,999,995.50

Insider Selling (Last 12 Months): $612,000.00

Sana Biotechnology Insider Trading History Chart

Sana Biotechnology Share Price & Price History

^$2.35

▼ -0.18 (-7.11%)

As of 11/21/2024 01:00 AM ET

Days: 30 | 90 | 365

“This Changes Everything” - Trump Hands Millions Massive IRS Gift

From Colonial Metals | Ad

Now it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as we wait for Trump's agenda to kick in…

>> YES! Send Me My FREE Gold Guide!

Sana Biotechnology Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/24/2024	Richard Mulligan	Director	Sell	150,000	$4.08	$612,000.00	2,848,121
2/8/2024	Robert Nelsen	Director	Buy	1,818,181	$5.50	$9,999,995.50	12,446,022
6/6/2023	Ventures Fund V Gener Flagship	Major Shareholder	Sell	203,758	$6.31	$1,285,712.98	1,403,037
5/26/2023	Ventures Fund V Gener Flagship	Major Shareholder	Sell	82,000	$6.23	$510,860.00	1,425,334
5/24/2023	Ventures Fund V Gener Flagship	Major Shareholder	Sell	347,870	$6.57	$2,285,505.90	1,447,791
2/3/2023	Joshua H Bilenker	Director	Buy	20,000	$25.00	$500,000.00	20,000
3/21/2022	Patrick Y Yang	Director	Buy	28,000	$7.30	$204,400.00
2/18/2022	James J Macdonald	EVP	Sell	333	$6.28	$2,091.24

“This Changes Everything” - Trump Hands Millions Massive IRS Gift

From Colonial Metals | Ad

Now it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as we wait for Trump's agenda to kick in…

>> YES! Send Me My FREE Gold Guide!

SEC Filings (Institutional Ownership Changes) for Sana Biotechnology (NASDAQ:SANA)

88.23% of Sana Biotechnology stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Sana Biotechnology Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/19/2024	Barclays PLC	318,910	$1.33M	0.0%	+126.6%	0.143%
11/16/2024	Geode Capital Management LLC	3,166,480	$13.18M	0.0%	+9.6%	1.418%
11/15/2024	Barclays PLC	318,910	$1.33M	0.0%	+126.6%	0.143%
11/15/2024	Zimmer Partners LP	348,700	$1.45M	0.0%	-5.4%	0.156%
11/15/2024	EP Wealth Advisors LLC	10,910	$45K	0.0%	N/A	0.005%
11/15/2024	Jane Street Group LLC	94,993	$0.40M	0.0%	-66.9%	0.043%
11/15/2024	State Street Corp	6,627,320	$27.57M	0.0%	+4.2%	2.968%
11/15/2024	Stifel Financial Corp	10,265	$43K	0.0%	N/A	0.005%
11/15/2024	Erste Asset Management GmbH	40,000	$0.17M	0.0%	N/A	0.018%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	253,899	$1.06M	0.0%	+2.8%	0.114%
11/14/2024	Zurcher Kantonalbank Zurich Cantonalbank	35,196	$0.15M	0.0%	+17.9%	0.016%
11/13/2024	D.A. Davidson & CO.	31,580	$0.13M	0.0%	-11.2%	0.014%
11/13/2024	FMR LLC	31,609,175	$131.49M	0.0%	+16.3%	14.157%
11/12/2024	Charles Schwab Investment Management Inc.	1,047,846	$4.36M	0.0%	+11.2%	0.471%
11/9/2024	Intech Investment Management LLC	57,698	$0.24M	0.0%	N/A	0.026%
11/6/2024	Cornercap Investment Counsel Inc.	16,218	$67K	0.0%	N/A	0.007%
11/5/2024	Baillie Gifford & Co.	10,278,084	$42.76M	0.0%	-2.8%	4.620%
10/31/2024	Principal Financial Group Inc.	12,364	$51K	0.0%	-52.0%	0.006%
10/25/2024	China Universal Asset Management Co. Ltd.	42,787	$0.18M	0.0%	+64.4%	0.019%
10/24/2024	Bristlecone Advisors LLC	50,000	$0.21M	0.0%	N/A	0.022%
10/18/2024	Blue Trust Inc.	13,129	$55K	0.0%	+1,246.6%	0.006%
8/16/2024	Algert Global LLC	13,286	$73K	0.0%	N/A	0.006%
8/15/2024	Susquehanna Fundamental Investments LLC	43,342	$0.24M	0.0%	-67.7%	0.020%
8/15/2024	The Manufacturers Life Insurance Company	312,031	$1.70M	0.0%	+8.0%	0.141%
8/15/2024	Dark Forest Capital Management LP	27,314	$0.15M	0.0%	+112.0%	0.012%
8/14/2024	Squarepoint Ops LLC	126,572	$0.69M	0.0%	+318.8%	0.057%
8/14/2024	Marshall Wace LLP	187,713	$1.03M	0.0%	-78.4%	0.085%
8/14/2024	Integral Health Asset Management LLC	1,200,000	$6.55M	0.6%	+22.4%	0.539%
8/14/2024	ProShare Advisors LLC	26,526	$0.15M	0.0%	-18.9%	0.012%
8/14/2024	Profund Advisors LLC	63,083	$0.34M	0.0%	-18.3%	0.028%
8/13/2024	Ensign Peak Advisors Inc	68,050	$0.37M	0.0%	N/A	0.031%
8/12/2024	XTX Topco Ltd	18,249	$100K	0.0%	N/A	0.008%
8/12/2024	E Fund Management Co. Ltd.	20,675	$0.11M	0.0%	-11.5%	0.009%
8/9/2024	Renaissance Technologies LLC	49,900	$0.27M	0.0%	-71.1%	0.023%
8/9/2024	Dimensional Fund Advisors LP	522,745	$2.85M	0.0%	-0.4%	0.236%
8/9/2024	Massachusetts Financial Services Co. MA	58,801	$0.32M	0.0%	-75.4%	0.027%
8/5/2024	Arizona State Retirement System	37,028	$0.20M	0.0%	+36.7%	0.017%
8/3/2024	TD Asset Management Inc	404,348	$2.21M	0.0%	-22.4%	0.183%
8/1/2024	Rhumbline Advisers	181,903	$0.99M	0.0%	+16.0%	0.082%
7/29/2024	Principal Financial Group Inc.	25,781	$0.14M	0.0%	-29.2%	0.012%
7/29/2024	Zurcher Kantonalbank Zurich Cantonalbank	29,858	$0.16M	0.0%	+20.6%	0.013%
7/26/2024	Bank of New York Mellon Corp	431,744	$2.36M	0.0%	+26.5%	0.195%
7/25/2024	Baillie Gifford & Co.	10,571,200	$57.72M	0.0%	-0.8%	4.773%
7/11/2024	Clarius Group LLC	63,184	$0.35M	0.0%	+34.9%	0.029%
5/28/2024	Teachers Retirement System of The State of Kentucky	104,442	$1.05M	0.0%	-14.0%	0.047%
5/17/2024	Zimmer Partners LP	202,500	$2.03M	0.0%	N/A	0.091%
5/16/2024	California State Teachers Retirement System	98,279	$0.98M	0.0%	-5.0%	0.044%
5/15/2024	Baker BROS. Advisors LP	2,380,949	$23.81M	0.3%	+19.0%	1.075%
5/15/2024	Price T Rowe Associates Inc. MD	3,695,459	$36.96M	0.0%	+2.8%	1.668%
5/15/2024	Lazard Asset Management LLC	4,814	$47K	0.0%	-35.6%	0.002%
5/14/2024	Capital World Investors	5,449,035	$54.49M	0.0%	+255.8%	2.460%
5/10/2024	Vanguard Group Inc.	12,155,173	$121.55M	0.0%	+24.1%	5.514%
5/9/2024	State Board of Administration of Florida Retirement System	16,978	$0.17M	0.0%	-36.4%	0.008%
5/8/2024	ProShare Advisors LLC	32,690	$0.33M	0.0%	+14.8%	0.015%
5/7/2024	Susquehanna Fundamental Investments LLC	134,309	$1.34M	0.1%	N/A	0.061%
5/7/2024	Susquehanna Portfolio Strategies LLC	81,695	$0.82M	0.0%	-63.4%	0.037%
5/7/2024	SG Americas Securities LLC	11,513	$0.12M	0.0%	-52.8%	0.005%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	57,535	$0.58M	0.0%	-70.9%	0.026%
5/1/2024	Baillie Gifford & Co.	10,656,279	$106.56M	0.1%	+5.0%	4.834%
4/30/2024	Hartline Investment Corp	13,650	$0.14M	0.0%	N/A	0.006%
4/29/2024	Principal Financial Group Inc.	36,394	$0.36M	0.0%	-7.2%	0.017%
4/29/2024	China Universal Asset Management Co. Ltd.	42,400	$0.42M	0.1%	+86.0%	0.019%
4/5/2024	Los Angeles Capital Management LLC	70,245	$0.70M	0.0%	-47.8%	0.032%
2/15/2024	PFM Health Sciences LP	1,883,337	$7.68M	0.5%	+51.4%	0.955%
2/15/2024	HarbourVest Partners LLC	117,694	$0.48M	0.2%	-14.5%	0.060%
2/13/2024	Rafferty Asset Management LLC	437,614	$1.79M	0.0%	+34.7%	0.222%
2/9/2024	Corient Private Wealth LLC	413,360	$1.69M	0.0%	+46.1%	0.210%
2/8/2024	Massachusetts Financial Services Co. MA	1,053,330	$4.30M	0.0%	-0.6%	0.534%
2/7/2024	Teacher Retirement System of Texas	22,226	$91K	0.0%	-9.2%	0.011%
2/7/2024	E Fund Management Co. Ltd.	23,361	$95K	0.0%	+40.0%	0.012%
2/6/2024	Swiss National Bank	194,100	$0.79M	0.0%	+3.5%	0.098%
2/6/2024	New York Life Investment Management LLC	105,612	$0.43M	0.0%	-2.9%	0.054%
2/5/2024	Victory Capital Management Inc.	13,340	$54K	0.0%	N/A	0.007%
2/2/2024	Simplex Trading LLC	18,080	$73K	0.0%	+31.3%	0.009%
2/1/2024	New York State Common Retirement Fund	40,564	$0.17M	0.0%	+5.4%	0.021%
1/30/2024	Zurcher Kantonalbank Zurich Cantonalbank	16,257	$66K	0.0%	+42.1%	0.008%
1/26/2024	Baillie Gifford & Co.	10,150,017	$41.41M	0.0%	-0.5%	5.149%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	197,386	$0.81M	0.0%	+286.4%	0.100%
1/24/2024	Arizona State Retirement System	27,527	$0.11M	0.0%	+12.2%	0.014%
1/24/2024	China Universal Asset Management Co. Ltd.	22,800	$93K	0.0%	+351.8%	0.012%
1/12/2024	SG Americas Securities LLC	24,370	$99K	0.0%	N/A	0.012%
12/18/2023	Vanguard Group Inc.	9,167,585	$35.48M	0.0%	+1.2%	4.651%
12/6/2023	Citigroup Inc.	145,370	$0.56M	0.0%	+10.3%	0.074%
11/22/2023	Public Sector Pension Investment Board	1,635,514	$6.33M	0.0%	-69.6%	0.830%
11/15/2023	GSA Capital Partners LLP	540,250	$2.09M	0.2%	N/A	0.274%
11/14/2023	Trexquant Investment LP	136,426	$0.53M	0.0%	N/A	0.069%
11/14/2023	Profund Advisors LLC	55,314	$0.21M	0.0%	-10.0%	0.028%
11/13/2023	FMR LLC	15,898,729	$61.53M	0.0%	-4.5%	8.065%
11/13/2023	Rafferty Asset Management LLC	324,882	$1.26M	0.0%	-3.2%	0.165%
11/13/2023	Baillie Gifford & Co.	10,204,375	$39.49M	0.0%	-5.8%	5.176%
11/9/2023	Harvard Management Co. Inc.	216,376	$0.84M	0.1%	-53.8%	0.110%
11/9/2023	Deutsche Bank AG	478,482	$1.85M	0.0%	+1.8%	0.243%
11/9/2023	Citigroup Inc.	145,370	$0.56M	0.0%	+10.3%	0.074%
11/9/2023	Skandinaviska Enskilda Banken AB publ	313,900	$1.22M	0.0%	N/A	0.159%
11/9/2023	Mitsubishi UFJ Trust & Banking Corp	232,830	$0.90M	0.0%	-6.4%	0.118%
11/8/2023	Massachusetts Financial Services Co. MA	1,060,140	$4.10M	0.0%	-0.8%	0.538%
11/8/2023	New York Life Investment Management LLC	108,711	$0.42M	0.0%	-13.7%	0.055%
11/7/2023	Barclays PLC	205,567	$0.80M	0.0%	+3.1%	0.104%
11/7/2023	Jump Financial LLC	13,322	$52K	0.0%	N/A	0.007%
11/2/2023	Principal Financial Group Inc.	42,664	$0.17M	0.0%	+13.1%	0.022%

Data available starting January 2016

Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. It develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, B-cell-mediated autoimmune, and others. The company's product candidates include SC291 that is used as allogeneic cell therapies for hematologic malignancies; ARDENT for a potential treatment for non-Hodgkin's lymphoma, and chronic lymphoblastic leukemia; GLEAM, to treat multiple autoimmune disorders that involve production of autoimmune antibodies, including lupus nephritis, extrarenal lupus, antineutrophil cytoplasmic antibody -associated vasculitis, and others. It is developing SC262 to treat patients with relapsed and/or refractory B-cell malignancies; SC255 for multiple myeloma treatment; SC379, a therapy for patients with certain central nervous system disorders healthy allogeneic glial progenitor cells; SC451, a product candidate to treat diabetes, with an initial focus on type 1 diabetes mellitus; and UP421 that reduces long-term exogenous insulin dependence. The company has an option and license agreement with Beam Therapeutics Inc. for use of Beam's proprietary CRISPR Cas12b nuclease editing technology to research, develop, and commercialize engineered cell therapy products; and a license agreement with Harvard College to access certain intellectual property for the development of hypoimmune-modified cells. The company was formerly known as FD Therapeutics, Inc. and changed its name to Sana Biotechnology, Inc. in September 2018. Sana Biotechnology, Inc. was incorporated in 2018 and is headquartered in Seattle, Washington.

Today's Range

Now: $2.35

$2.33

$2.60

50 Day Range

MA: $3.72

$2.34

$4.62

52 Week Range

Now: $2.35

$2.29

$12.00

Volume

1,368,603 shs

Average Volume

2,144,136 shs

Market Capitalization

$524.68 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.44

Who are the company insiders with the largest holdings of Sana Biotechnology?: Sana Biotechnology's top insider investors include:
Robert Nelsen (Director)
Richard Mulligan (Director)
Ventures Fund V Gener Flagship (Major Shareholder)
Joshua H Bilenker (Director)
Learn More about top insider investors at Sana Biotechnology.
Who are the major institutional investors of Sana Biotechnology?: Sana Biotechnology's top institutional investors include:
FMR LLC — 14.16%
Baillie Gifford & Co. — 4.62%
State Street Corp — 2.97%
Geode Capital Management LLC — 1.42%
Charles Schwab Investment Management Inc. — 0.47%
Ikarian Capital LLC — 0.00%
Learn More about top institutional investors of Sana Biotechnology stock.
Which institutional investors are selling Sana Biotechnology stock?: In the last quarter, SANA stock was sold by these institutional investors:
Baillie Gifford & Co.
Jane Street Group LLC
Zimmer Partners LP
Principal Financial Group Inc.
D.A. Davidson & CO.
Which institutional investors are buying Sana Biotechnology stock?: Within the last quarter, SANA stock was purchased by institutional investors including:
FMR LLC
Ikarian Capital LLC
Geode Capital Management LLC
LMR Partners LLP
State Street Corp
Barclays PLC
Barclays PLC
Charles Schwab Investment Management Inc.
Within the previous year, these company insiders have bought Sana Biotechnology stock:
Robert Nelsen (Director)
Richard Mulligan (Director)
Learn More investors buying Sana Biotechnology stock.